Table 1.
Genotype
|
Tumor regression
|
|
---|---|---|
Complete
|
Incomplete
|
|
MTB/TWNT/p53(+/+) | 33 (94%) | 2 (6%) |
MTB/TWNT/p53(+/−) | 18 (60%) | 12 (40%) |
Tumors with p53 LOH | 5 (71%) | 2 (29%) |
Tumors without p53 LOH | 13 (57%) | 10 (43%) |
Mammary tumors arising in MTB/TWNT/p53(+/+) and MTB/TWNT/p53(+/−) mice were biopsied, and tumor size was monitored following doxycycline withdrawal. Tumors occurring in p53(+/−) mice were significantly less likely to regress completely following doxycycline withdrawal than tumors occurring in p53(+/+) mice (p < 0.005, chi-square). In addition, tumors that failed to fully regress promptly resumed growth.